What's New
Bug Fixes, Improved performance of the application
App Description
An app for the TAK-660-403 Protocol. Evaluation of long-term safety of ADYNOVI / ADYNOVATE(Antihaemophilic Factor [Recombinant] PEGylated, rurioctocog alfa pegol) in patients with haemophilia A – An ADYNOVI / ADYNOVATE Post-Authorisation Safety Study (PASS)
App Changes
- July 15, 2020 Initial release
- September 15, 2023 New version 1.1